2 results
Approved WMOCompleted
The objective of this project is to assess the applicability of [11C]GMOM for in vivo imaging of the NMDA receptor.
Approved WMORecruiting
The primary objective of this trial is to study the effect of the moderate CYP3A4 inhibitor erythromycin on the pharmacokinetics of palbociclib, measured as AUC0-24h, Cmax and Cmin.The secondary objective of this trial is to compare the incidence…